Riluzole in generalized anxiety disorder: An open-label trial

被引：0
|
作者：
Mathew, SJ [1 ]
Amiel, JM [1 ]
Coplan, JD [1 ]
Fitterling, HA [1 ]
Sackeim, HA [1 ]
Gorman, JM [1 ]
机构：
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2004年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 50 条
  • [1] Riluzole in generalized anxiety disorder: An open-label trial
    Amiel, JM
    Mathew, SJ
    Coplan, JD
    Fitterling, HA
    Sackeim, HA
    Gorman, JM
    DEPRESSION AND ANXIETY, 2005, 22 (04) : 192 - 192
  • [2] Open-label trial of riluzole in generalized anxiety disorder
    Mathew, SJ
    Amiel, JM
    Coplan, JD
    Fitterling, HA
    Sackeim, HA
    Gorman, JM
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (12): : 2379 - 2381
  • [3] An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder
    Menza, Matthew A.
    Dobkin, Roseanne D.
    Marin, Humberto
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) : 207 - 210
  • [4] An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder
    Kaplan, Alicia
    Franzen, Michael D.
    Nickell, P. V.
    Ransom, Danielle
    Lebovitz, Paul J.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2014, 18 (01) : 11 - 15
  • [5] Open-label pilot study of ziprasidone for refractory generalized anxiety disorder
    Snyderman, SH
    Rynn, MA
    Rickels, K
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 497 - 499
  • [6] Tiagabine for the treatment of generalized anxiety disorder: A randomized, open-label, clinical trial with paroxetine as a positive control
    Rosenthal, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (10) : 1245 - 1249
  • [7] An open-label trial of escitalopram in children and adolescents with social anxiety disorder
    Isolan, Luciano
    Pheula, Gabriel
    Salum, Giovanni Abrahao, Jr.
    Oswald, Sylvia
    Rohde, Luis Augusto
    Manfro, Gisele Gus
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 751 - 759
  • [8] Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial
    Feusner, Jamie D.
    Kerwin, Lauren
    Saxena, Sanjaya
    Bystritsky, Alexander
    PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 81 - 93
  • [9] Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
    Coric, V
    Taskiran, S
    Pittenger, C
    Wasylink, S
    Mathalon, DH
    Valentine, G
    Saksa, J
    Wu, YT
    Gueorguieva, R
    Sanacora, R
    Malison, RT
    Krystal, JH
    BIOLOGICAL PSYCHIATRY, 2005, 58 (05) : 424 - 428
  • [10] Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study
    Schutters, SIJ
    Van Megen, HGJM
    Westenberg, HGM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S535 - S535
12345